The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no longer in short supply. CBS News New York reporter Ali Bauman reports on whether the supply change could lead to consumers paying more.
FDA says Ozempic, Wegovy are not in short supply anymore, which could impact prices
Categories:
Related Post
White House calls Democrat criticism of DOGE ‘unacceptable’ and ‘incredibly alarming’White House calls Democrat criticism of DOGE ‘unacceptable’ and ‘incredibly alarming’
White House press secretary Karoline Leavitt slammed Democrats Wednesday for their criticism of the Department of Government Efficiency (DOGE), calling it “unacceptable” and “incredibly alarming.” “Some elected Democrats are so steamed
NIRF Ranking 2024: AIIMS Delhi tops medical category, Check India’s top 5 medical colleges hereNIRF Ranking 2024: AIIMS Delhi tops medical category, Check India’s top 5 medical colleges here
The Ministry of Education unveiled the NIRF 2024 rankings, with AIIMS, Delhi retaining the top spot in the Medical category. Notable changes included altering the faculty-to-student ratio and adding new
DOJ seeks to block Jan. 6 defendants from attending Trump inaugurationDOJ seeks to block Jan. 6 defendants from attending Trump inauguration
Attorneys at the Department of Justice are urging federal judges to reject petitions from at least two Jan. 6 defendants who are asking that they be allowed to return to